BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8125216)

  • 21. Time response of carboplatin-induced nephrotoxicity in rats.
    Husain K; Whitworth C; Rybak LP
    Pharmacol Res; 2004 Sep; 50(3):291-300. PubMed ID: 15225673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of desferrioxamine on cisplatin-induced nephrotoxicity in normal rats.
    al-Harbi MM; Osman AM; al-Gharably NM; al-Bekairi AM; al-Shabanah OA; Sabah DM; Raza M
    Chemotherapy; 1995; 41(6):448-54. PubMed ID: 8529435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cisplatin nephrotoxicity: in vitro studies with precision-cut rabbit renal cortical slices.
    Phelps JS; Gandolfi AJ; Brendel K; Dorr RT
    Toxicol Appl Pharmacol; 1987 Sep; 90(3):501-12. PubMed ID: 3310337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice.
    Endo K; Akamatsu K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
    Anticancer Res; 1992; 12(1):49-58. PubMed ID: 1567181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cisplatin and carboplatin induced changes in the neurohypophysis and parathyroid, and their role in nephrotoxicity.
    Aggarwal SK; Fadool JM
    Anticancer Drugs; 1993 Apr; 4(2):149-62. PubMed ID: 8490193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of a cisplatin-chondroitin sulfate A complex in reducing the nephrotoxicity of cisplatin.
    Zhang JS; Imai T; Otagiri M
    Arch Toxicol; 2000 Aug; 74(6):300-7. PubMed ID: 11005675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Studies on the mechanisms of renal damages induced by nephrotoxic compounds].
    Yamada T
    Nihon Hoigaku Zasshi; 1995 Dec; 49(6):447-57. PubMed ID: 8583688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnesium depletion enhances cisplatin-induced nephrotoxicity.
    Lajer H; Kristensen M; Hansen HH; Nielsen S; Frøkiaer J; Ostergaard LF; Christensen S; Daugaard G; Jonassen TE
    Cancer Chemother Pharmacol; 2005 Nov; 56(5):535-42. PubMed ID: 15947931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative toxicity and renal distribution of the platinum analogs tetraplatin, CHIP, and cisplatin at equimolar doses in the Fischer 344 rat.
    Smith JH; Smith MA; Litterst CL; Copley MP; Uozumi J; Boyd MR
    Fundam Appl Toxicol; 1988 Jan; 10(1):45-61. PubMed ID: 3350229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gamma-glutamyl transpeptidase-deficient mice are resistant to the nephrotoxic effects of cisplatin.
    Hanigan MH; Lykissa ED; Townsend DM; Ou CN; Barrios R; Lieberman MW
    Am J Pathol; 2001 Nov; 159(5):1889-94. PubMed ID: 11696449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined Administration of l-Carnitine and Ascorbic Acid Ameliorates Cisplatin-Induced Nephrotoxicity in Rats.
    Alabi QK; Akomolafe RO; Olukiran OS; Nafiu AO; Adefisayo MA; Owotomo OI; Omole JG; Olamilosoye KP
    J Am Coll Nutr; 2018 Jul; 37(5):387-398. PubMed ID: 29425480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nephrotoxicity of cisplatin, carboplatin and transplatin. A comparative in vitro study.
    Hannemann J; Baumann K
    Arch Toxicol; 1990; 64(5):393-400. PubMed ID: 2169720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose response of carboplatin-induced nephrotoxicity in rats.
    Husai K; Jagannathan R; Hasan Z; Trammell GL; Rybak LP; Hazelrigg SR; Somani SM
    Pharmacol Toxicol; 2002 Aug; 91(2):83-9. PubMed ID: 12420797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of cisplatin nephrotoxicity.
    Weiner MW; Jacobs C
    Fed Proc; 1983 Oct; 42(13):2974-8. PubMed ID: 6684595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effect of piperacillin against the nephrotoxicity of cisplatin in rats.
    Hayashi T; Watanabe Y; Kumano K; Kitayama R; Muratani T; Yasuda T; Saikawa I; Katahira J; Kumada T; Shimizu K
    Antimicrob Agents Chemother; 1989 Apr; 33(4):513-8. PubMed ID: 2729945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective action of glycine in cisplatin nephrotoxicity.
    Heyman SN; Rosen S; Silva P; Spokes K; Egorin MJ; Epstein FH
    Kidney Int; 1991 Aug; 40(2):273-9. PubMed ID: 1942775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of nitric oxide synthase aggravates cisplatin-induced nephrotoxicity: effect of 2-amino-4-methylpyridine.
    Saad SY; Najjar TA; Daba MH; Al-Rikabi AC
    Chemotherapy; 2002; 48(6):309-15. PubMed ID: 12673106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nephrotoxicity of acyclovir and cis-diamminedichloroplatinum(II)--effect of co-administration in rats.
    Hannemann J; Wunderle W; Baumann K
    J Cancer Res Clin Oncol; 1992; 118(3):181-6. PubMed ID: 1548282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental study of renal disorder caused by oxaliplatin in rat renal cortical slices.
    Kanou T; Uozumi J; Soejima K; Tokuda Y; Masaki Z
    Clin Exp Nephrol; 2004 Dec; 8(4):310-5. PubMed ID: 15619029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison in rodents of renal and intestinal toxicity of cisplatin and a new water-soluble antitumor platinum complex: N-methyl-iminodiacetato-diaminocyclohexane platinum (II).
    Newman RA; Khokhar AR; Sunderland BA; Travis EL; Bulger RE
    Toxicol Appl Pharmacol; 1986 Jul; 84(3):454-63. PubMed ID: 3726868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.